Isis Pharmaceuticals Inc (ISIS :)
| Extended Hours | --- |
---
|
--- | --- |
|
--- |
---
|
--- | --- |
ISIS FEATURED NEWS & ANALYSIS
LATEST ABOUT THIS TOPIC ON CNBC.COM
-
Lightning Round: Disney, AMD & More 04 Jun 2013 - CNBC.com
-
MORE FROM CNBC
-
Lightning Round: Disney, AMD & More 04 Jun 2013 - CNBC.com
-
MORE FROM OUR PARTNERS
-
Isis Pharmaceuticals Making Antisense 17 Jun 2013 - Seeking Alpha
-
Near A 52-Week Low, Is OncoGenex Pharmaceuticals A Buy? 13 Jun 2013 - Seeking Alpha
-
When It Comes To Biotech, Diversity Is Key 12 Jun 2013 - Seeking Alpha
-
Aegerion's Pricing Power Sends Shares Flying 22 May 2013 - Seeking Alpha
LATEST TRANSCRIPTS
-
Isis Pharmaceuticals' Management Presents at Goldman Sachs 34th Annual... 12 Jun 2013 - Seeking Alpha
-
Isis Pharmaceuticals' Management Discuss Cancer Franchise (Transcript) 04 Jun 2013 - Seeking Alpha
-
Isis Pharmaceuticals' Management Presents at 38th Annual Deutsche Bank... 30 May 2013 - Seeking Alpha
-
Isis Pharmaceuticals' Management Presents at UBS Global Healthcare Con... 20 May 2013 - Seeking Alpha
PRESS RELEASES
-
Industry Shows a Healthy Pulse with Priority Reviews, Positive Results... 18 Jun 2013 - PR Newswire
-
Isis Pharmaceuticals to Present a General Corporate Update at its 2013... 18 Jun 2013 - PR Newswire
-
Research and Markets: Pituitary ACTH Hypersecretion (Cushing's Disease... 17 Jun 2013 - Business Wire
-
Regulus Names Stelios Papadopoulos, Ph.D. as Chairman of its Board of ... 11 Jun 2013 - PR Newswire
-
Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinic... 10 Jun 2013 - PR Newswire
-
Isis Pharmaceuticals Earns $6 Million Payment from AstraZeneca 06 Jun 2013 - PR Newswire
-
Research and Markets: Hormone Refractory (Castration Resistant, Androg... 05 Jun 2013 - Business Wire
-
Isis Pharmaceuticals to Present at the Goldman Sachs 34th Annual Globa... 05 Jun 2013 - PR Newswire
-
Isis Pharmaceuticals Reports Encouraging Data on ISIS-STAT3rx in Patie... 03 Jun 2013 - PR Newswire
-
Isis Pharmaceuticals Earns $10 Million Milestone Payment from AstraZen... 03 Jun 2013 - PR Newswire
